Displaying items by tag: department of neurology

Learn about Lou Gehrig’s disease at the second UAB Neuroscience Café at the Hoover Library.
UAB has teamed with the Michael J. Fox Foundation to look for genetic biomarkers for Parkinson’s disease.
Neuroscience Café serves healthy portions of fascinating topics in the field of neuroscience at 6:30 p.m. on the third Monday of every month.
Researchers at UAB show that high-intensity strength training improves mobility, mood and overall quality of life for Parkinson’s patients.
CNET promotes the discovery of novel treatments for neurodegenerative disorders, teaches scientists and clinicians about these diseases, and facilitates the application of these discoveries to the clinical care of patients.
Gel form of a medication for Parkinson’s disease speeds response time over traditional pills.
This group, newly established as an AES committee, is charged with promoting and tracking progress in areas targeted as potential epilepsy benchmarks by NINDS.

The program supports and cultivates students interested in Parkinson’s related research projects.

The network has the largest group of well-characterized pediatric MS cases in the world.

Bebin is co-director of the UAB Tuberous Sclerosis Clinic and a founding member of the TSC Clinical Research Consortium.

UAB Neurology adds to evidence that massive, second-wave reaction kills nerve cells.

UAB expands research into dystonia with a generous gift from the Joel Johnson family.

UAB researchers partner with the Michael J. Fox Foundation on a new study of Parkinson’s disease risk factors, including a reduced sense of smell.

A UAB study links the Mediterranean diet to better memory.

Michael Warren is president and CEO of Children's of Alabama.

Standaert is director of the Center for Neurodegeneration and Experimental Therapeutics and the Division of Movement Disorders in Neurology.

Page 12 of 14